Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine plus propofol for rigid cystoscopic ureteral stent removal in males
ChiCTR2400088880Phase 4Not yet recruiting
- Sponsor
- First People's Hospital of Lin'an District, Hangzhou
- Start
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of esketamine in Lithiasis (4 arms), sponsored by First People's Hospital of Lin'an District, Hangzhou. Primary endpoint: Incidence of intraoperative hypoxemia. Planned start Aug 2024; status: not yet recruiting.
02
Drugs
esketamine
03
Conditions
Lithiasis
Beyond the preview
Go deeper on ChiCTR2400088880.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400088880.